ACR Appropriateness Criteria on resectable rectal cancer: expert panel on radiation oncology--rectal/anal cancer

Int J Radiat Oncol Biol Phys. 2008 Apr 1;70(5):1427-30. doi: 10.1016/j.ijrobp.2007.09.029.

Abstract

In what arguably may be the most pivotal recent trial in the area of resectable rectal cancer management, a randomized trial from Germany has established a regimen of preoperative chemoradiotherapy and surgery followed by additional cycles of chemotherapy alone as the standard of care for clinical stages T3 or T4, or for node-positive rectal cancer. Other clinical studies from the United States, Europe, and Asia have also influenced the treatment strategies of operable rectal cancer, as various approaches using preoperative or postoperative radiotherapy, with or without chemotherapy, have been examined. A summary of the major randomized clinical trials spanning the past several decades is provided.

Publication types

  • Practice Guideline
  • Review

MeSH terms

  • Combined Modality Therapy / methods
  • Combined Modality Therapy / standards
  • Humans
  • Rectal Neoplasms* / drug therapy
  • Rectal Neoplasms* / radiotherapy
  • Rectal Neoplasms* / surgery
  • Societies, Medical
  • United States